Pancreatic cancer

Kleeff, Jorg, Korc, Murray, Apte, Minoti, La Vecchia, Carlo, Johnson, Colin D., Biankin, Andrew V., Neale, Rachel E., Tempero, Margaret +3 more·2016·Nature Reviews Disease Primers
DOI 10.1038/nrdp.2016.22

Cites (275)

Items 201–275 of 275

  1. Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: A meta-analysis
    Xinzhe Yu, Junpeng Li, Deliang Fu, Di Yang, F. Yang, S.J. Hao, C. Jin · 2014 · European Journal of Surgical Oncology
  2. Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification
    Junko Tanizaki, Isamu Okamoto, Kazuko Sakai, Kazuhiko Nakagawa · 2011 · British Journal of Cancer
  3. The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
    Lai Mun Wang, Michael A. Silva, Zenobia D’Costa, Robin Bockelmann, Zahir F. Soonawalla, Stanley K. Liu, Eric E. O’Neill, Somnath Mukherjee, William Gillies McKenna, Ruth J. Muschel et al. · 2015 · Oncotarget
  4. Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency
    Linghua Wang, Shuichi Tsutsumi, Tokuichi Kawaguchi, Koichi Nagasaki, Kenji Tatsuno, Shogo Yamamoto, Fei Sang, Kohtaro Sonoda, Minoru Sugawara, Akio Saiura et al. · 2011 · Genome Research
  5. Targeting cancer cell metabolism in pancreatic adenocarcinoma
    Romain Cohen, Cindy Neuzillet, Annemilaï Tijeras‐Raballand, Sandrine J. Faivre, Armand D.E. Gramont, Éric Raymond · 2015 · Oncotarget
  6. Ibrutinib Exerts Potent Antifibrotic and Antitumor Activities in Mouse Models of Pancreatic Adenocarcinoma
    Daniel Massó-Vallés, Toni Jauset, Erika Serrano, Nicole M. Sodir, Kim Pedersen, Nesrine I. Affara, Jonathan Richard Whitfield, Marie-Ève Beaulieu, Gérard I. Evan, Laurence Elias et al. · 2015 · Cancer Research
  7. Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)
    Stefan Heinrich, Bernhard C. Pestalozzi, Mickaël Lesurtel, Frederik Christiaan Berrevoet, Stéphanie Laurent, Jean‐Robert Delpéro, Jean‐Luc Raoul, Phillippe Bachellier, Patrick Dufour, Markus Hermann Moehler et al. · 2011 · BMC Cancer
  8. Serum Fatty Acid Synthase as a Marker of Pancreatic Neoplasia
    Walter Kim, Seung‐Mo Hong, Sineád M. Nyhan, Marcia Irene Canto, Neal S. Fedarko, Alison P. Klein, Margaret Griffith, Noriyuki Omura, Susan M. Medghalchi, Frank Kuhajda et al. · 2009 · Cancer Epidemiology Biomarkers & Prevention
  9. Definition of Microscopic Tumor Clearance (R0) in Pancreatic Cancer Resections
    Anna Melissa Schlitter, Iréne Esposito · 2010 · Cancers
  10. Resection of Primary Pancreatic Cancer and Liver Metastasis: A Systematic Review
    Christoph W. Michalski, Mert Erkan, Norbert Hüser · 2008 · Digestive Surgery
  11. Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients
    Khinh Ranh Voong, Jon M. Davison, Timothy Michael Pawlik et al. · 2009 · Human Pathology
  12. The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis
    Robert Lance Fine, David R. Fogelman, Stephen M. Schreibman, Manisha Desai, William H. Sherman, J.B. Strauss, Susan C. Guba, Riolan Andrade, John A. Chabot · 2007 · Cancer Chemotherapy and Pharmacology
  13. Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma
    Natalie Cook, Kristopher K. Frese, Tashinga E. Bapiro, Michael A. Jacobetz, Aarthi Gopinathan, Jodi L. Miller, Sudhir S. Rao, Tim Demuth, William Howat, Duncan Ian Jodrell et al. · 2012 · The Journal of Experimental Medicine
  14. Risk of pancreatic cancer in patients with cystic fibrosis: Table 1
    Patrick Maisonneuve, Bruce C. Marshall, Albert B. Lowenfels · 2007 · Gut
  15. Physical activity and risk of pancreatic cancer: a systematic review and meta-analysis
    Gundula Behrens, Carmen Jochem, Daniela Schmid, Marlen Keimling, Cristian Ricci, Michael Fred Leitzmann · 2015 · European Journal of Epidemiology
  16. Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience
    Ulrich Nitsche, Patrick Wenzel, Jens Thomas Siveke, Rickmer Braren, Konstantin Holzapfel, Anna Melissa Schlitter, Christian Stöß, Bo Kong, Iréne Esposito, Mert Erkan et al. · 2015 · Annals of Surgical Oncology
  17. Family history of cancer and the risk of cancer: a network of case-control studies.
    F. Turati, V. Edefonti, C. Bosetti, M. Ferraroni, M. Malvezzi, S. Franceschi, R. Talamini, M. Montella, F. Levi, L. Dal Maso et al. · 2013 · Annals of Oncology
  18. Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study.
    Pascal R. Hammel, F. Huguet, Jean‐Luc Van Laethem et al. · 2013 · Journal of Clinical Oncology
  19. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma
    Markus K. Diener, Christina Fitzmaurice, Guido Schwarzer, Christoph M. Seiler, Gerd Antes, Hanns‐Peter Knaebel, Markus Wolfgang Büchler · 2011 · Cochrane Database of Systematic Reviews
  20. A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer
    R. Rad, Lena Rad, Wei Wang, Alexander J. Strong, H. Ponstingl, I. Bronner, M. Mayho, K. Steiger, Julia Weber, Maren Hieber et al. · 2014 · Nature Genetics
  21. A systematic review on robotic pancreaticoduodenectomy
    Roberto Cirocchi, Stefano Partelli, Stefano Trastulli · 2013 · Surgical Oncology
  22. Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749)
    Michael Tachezy, Florian Gebauer, Cordula Petersen · 2014 · BMC Cancer
  23. Circulating Mesothelin Protein and Cellular Antimesothelin Immunity in Patients with Pancreatic Cancer
    Fabian Mc. Johnston, Marcus Chuan Beng Tan, Benjamin R. Tan, Matthew R. Porembka, Elizabeth M. Brunt, David C. Linehan, Peter O. Simon, Stacey M. Plambeck-Suess, Timothy J. Eberlein, Karl Erik Hellström et al. · 2009 · Clinical Cancer Research
  24. The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell–endothelial cell interactions: antiangiogenic implications in pancreatic cancer
    Mishaal B. Patel, Srinivasa P. Pothula, Zhihong Xu, Alexandra K. Lee, David Goldstein, Romano C. Pirola, Minoti Vivek Apte, Jeremy S. Wilson · 2014 · Carcinogenesis
  25. Meat and fish consumption and risk of pancreatic cancer: Results from the European Prospective Investigation into Cancer and Nutrition
    Sabine Rohrmann, Jakob Linseisen, Ute Nöthlings, Kim Overvad, Rikke Egeberg, Anne Marie Tjønneland, Marie‐Christine Boutron‐Ruault, Françoise Clavel‐Chapelon, Vanessa Cottet, Valeria Maria Pala et al. · 2012 · International Journal of Cancer
  26. Pancreatic cancer: Role of the immune system in cancer progression and vaccine-based immunotherapy
    Amedeo Amedei, Elena Niccolai, Domenico Prisco · 2014 · Human Vaccines & Immunotherapeutics
  27. Survival after Resection for Invasive Intraductal Papillary Mucinous Neoplasm and for Pancreatic Adenocarcinoma: A Multi-Institutional Comparison According to American Joint Committee on Cancer Stage
    Joshua A. Waters, Thomas Schnelldorfer, Juan R. Aguilar-Saavedra, Jey-Hsin Chen, Constantin Theodore Yiannoutsos, Keith D. Lillemoe, Michael B. Farnell, Michael G. Sarr, Christian Max Schmidt · 2011 · Journal of the American College of Surgeons
  28. The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy
    Katherine M. Bever, Elizabeth A. Sugar, Elaine O. Bigelow, Rajni B Sharma, Daniel A. Laheru, Christopher L. Wolfgang, Elizabeth M. Jaffee, Robert A. Anders, Ana De Jesus‐Acosta, Lei Zheng · 2014 · HPB
  29. Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions
    Albrecht Neeße, Anke Hahnenkamp, Heidi Griesmann, Malte Buchholz, Stephan A. Hahn, Abdelouahid Maghnouj, Volker Fendrich, Janine Ring, Bence Sipos, David Arthur Tuveson et al. · 2012 · Gut
  30. A modular and flexible ESC-based mouse model of pancreatic cancer
    M. Saborowski, A. Saborowski, John P. Morris, Benedikt Bosbach, Lukas E. Dow, J. Pelletier, D. Klimstra, S. Lowe · 2014 · Genes & Development
  31. Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage-stellate cell interaction
    Chan-Juan Shi, M. Washington, R. Chaturvedi, Y. Drosos, Frank L. Revetta, Connie J. Weaver, Emily Buzhardt, Fiona E Yull, T. S. Blackwell, B. Sosa-Pineda et al. · 2014 · Laboratory Investigation
  32. Pancreatic Cancer‐Induced Cachexia Is Jak2‐Dependent in Mice
    Marine Gilabert, Ezequiel Luis Calvo, Ana Airoldi, Tewfik Hamidi, Vincent Moutardier, Olivıer Turrini, Juan Iovanna · 2014 · Journal of Cellular Physiology
  33. Validity of the FACT Hepatobiliary (FACT-Hep) questionnaire for assessing disease-related symptoms and health-related quality of life in patients with metastatic pancreatic cancer
    David F Cella, Zeeshan A. Butt, Hedy Lee Kindler, Charles S. Fuchs, Sarah L Bray, Arie Barlev, Alan K. Oglesby · 2012 · Quality of Life Research
  34. Hypoxia-inducible factor 1α expression and its clinical significance in pancreatic cancer: A meta-analysis
    Long‐Yun Ye, Qi Zhang, Xueli Bai, Pankaj Prasoon, Qida Hu, Tingbo Liang · 2014 · Pancreatology
  35. Pancreatic cancer–associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation
    A. Jesse Gore, Samantha Deitz McElyea, Lakshmi Reddy Palam, Kelly E. Craven, Murray Korc · 2013 · Journal of Clinical Investigation
  36. Pancreatic cancer-associated stellate cells
    Thomas A. Mace, Mark Bloomston, Gregory B. Lesinski · 2013 · OncoImmunology
  37. Pancreatic cancer: surgery alone is not sufficient
    L. William Traverso · 2006 · Surgical Endoscopy
  38. ABO blood groups and pancreatic cancer risk and survival: Results from the PANcreatic Disease ReseArch (PANDoRA) consortium
    Cosmeri Rizzato, Daniele Campa, Raffaele Pezzilli, Pavel Souček, William Greenhalf, Gabriele Capurso, Renata Talar‐Wojnarowska, Anette Heller, Krzysztof Jamroziak, Kay‐Tee Khaw et al. · 2013 · Oncology Reports
  39. Extended Versus Standard Lymphadenectomy for Pancreatic Head Cancer: Meta-Analysis of Randomized Controlled Trials
    Bobby V.M. Dasari, Sandro Pasquali, Ravinder Vohra · 2015 · Journal of Gastrointestinal Surgery
  40. Pancreatic cancer genomics
    David Kuang-Fu Chang, Sean Michael Grimmond, Andrew Victor Biankin · 2014 · Current Opinion in Genetics & Development
  41. Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis
    Risch, H. A., Yu, H., Lu, L., Kidd, M. S. · 2015 · American Journal of Epidemiology
  42. Palliative resections versus palliative bypass procedures in pancreatic cancer—a systematic review
    Sonja Gillen, Tibor Schuster, Helmut Frieß · 2011 · The American Journal of Surgery
  43. High response rate and PFS with PEGPH20 added to nab-paclitaxel/gemcitabine in stage IV previously untreated pancreatic cancer patients with high-HA tumors: Interim results of a randomized phase II study.
    Sunil R. Hingorani, William Proctor Harris, Andrew Eugene Hendifar, Andrea J. Bullock, Xionghua Wu, Ya Fang Huang, Ping Jiang · 2015 · Journal of Clinical Oncology
  44. Predictors of survival in patients with malignant gastric outlet obstruction: A patient-oriented decision approach for palliative treatment
    Suzanne M. Jeurnink, Ewout Willem Steyerberg, Frank P. Vleggaar · 2011 · Digestive and Liver Disease
  45. Population Attributable Risk for Pancreatic Cancer in Northern Italy
    Valentina Rosato, Jerry Polesel, Cristina Bosetti, Diego Serraino, Eva Negri, Carlo La Vecchia · 2014 · Pancreas
  46. Nutrient-based dietary patterns and pancreatic cancer risk
    Cristina Bosetti, Francesca Bravi, Federica Turati, Valeria Carla Edefonti, Jerry Polesel, Adriano Decarli, Eva Negri, Renato Talamini, Silvia Franceschi, Carlo La Vecchia et al. · 2013 · Annals of Epidemiology
  47. Pancreatic stellate cells reduce insulin expression and induce apoptosis in pancreatic β-cells
    Kazuhiro Kikuta, Atsushi Masamune, Shin Hamada, Tetsuya Takikawa, Eriko Nakano, Tooru Shimosegawa · 2013 · Biochemical and Biophysical Research Communications
  48. Linear-array EUS improves detection of pancreatic lesions in high-risk individuals: a randomized tandem study
    Eun Ji Shin, Mark D. Topazian, Michael Goggins, Sapna Syngal, John R. Saltzman, Jeffrey H. Lee, James J. Farrell, Marcia Irene Canto · 2015 · Gastrointestinal Endoscopy
  49. Distal pancreatectomy with celiac axis resection: what are the added risks?
    Joal D. Beane, Michael Garrett House, Susan C. Pitt, E. Molly Kilbane, Bruce Lee Hall, Abishek D. Parmar, Taylor Sohn Riall, Henry Anthony Pitt · 2015 · HPB
  50. Signaling Pathways in Pancreatic Cancer
    Meir Preis, Murray Korc · 2011 · Critical Reviews in Eukaryotic Gene Expression
  51. Cancers in Australia in 2010 attributable to modifiable factors: introduction and overview
    David C. Whiteman, Penelope M. Webb, Adèle C. Green et al. · 2015 · Australian and New Zealand Journal of Public Health
  52. FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas
    Ujas N Parikh, Charles V. Marcus, Rutuparna Sarangi · 2015 · PET Clinics
  53. Cross-Species Antibody Microarray Interrogation Identifies a 3-Protein Panel of Plasma Biomarkers for Early Diagnosis of Pancreas Cancer
    Justin E. Mirus, Yuzheng Zhang, Christopher I. Li, Anna E Lokshin, Ross L. Prentice, Sunil R. Hingorani, Paul D. Lampe · 2015 · Clinical Cancer Research
  54. Current evidence for the diagnostic value of gadoxetic acid‐enhanced magnetic resonance imaging for liver metastasis
    Masakatsu Tsurusaki, Keitaro Sofue, Takamichi Murakami · 2016 · Hepatology Research
  55. Mesothelin Virus-Like Particle Immunization Controls Pancreatic Cancer Growth through CD8+ T Cell Induction and Reduction in the Frequency of CD4+foxp3+ICOS− Regulatory T Cells
    Sheng Zhang, Lin-Kin Yong, Dali Li · 2013 · PLoS ONE
  56. Subtyping Pancreatic Cancer
    Andrew Victor Biankin, Anirban Maitra · 2015 · Cancer Cell
  57. Thirty Years of Experience with Intraductal Papillary Mucinous Neoplasm of the Pancreas: From Discovery to International Consensus
    Masao Tanaka · 2014 · Digestion
  58. Hypoxia-induced endoplasmic reticulum stress characterizes a necrotic phenotype of pancreatic cancer
    Bo Kong, Tao Cheng, Weiwei Wu, Ivonne Regel, Susanne Raulefs, Helmut Frieß, Mert Erkan, Iréne Esposito, Jorg H. Kleeff, Christoph W. Michalski · 2015 · Oncotarget
  59. Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer
    Chris N Hurt, Somnath Mukherjee, John A. Bridgewater et al. · 2015 · International Journal of Radiation Oncology*Biology*Physics
  60. Targeted Screening of Individuals at High Risk for Pancreatic Cancer: Results of a Simulation Model
    Pari V. Pandharipande, Curtis R. Heberle, Emily C. Dowling, Chung Yin Kong, Angela C. Tramontano, Katherine E. Perzan, William Robert Brugge, Chin Hur · 2014 · Radiology
  61. Quality of Life in a Prospective, Multicenter Phase 2 Trial of Neoadjuvant Full-Dose Gemcitabine, Oxaliplatin, and Radiation in Patients With Resectable or Borderline Resectable Pancreatic Adenocarcinoma
    Pablo Emilio Serrano, Joseph M. Herman, Kent A. Griffith · 2014 · International Journal of Radiation Oncology*Biology*Physics
  62. Mining the genomes of exceptional responders
    David Kuang-Fu Chang, Sean Michael Grimmond, Thomas R. Jeffry Evans, Andrew Victor Biankin · 2014 · Nature reviews. Cancer
  63. Current and Future Care of Patients with the Cancer Anorexia-Cachexia Syndrome
    Egidio Del Fabbro · 2015 · American Society of Clinical Oncology Educational Book
  64. Quality of life assessment in advanced pancreatic adenocarcinoma: Results from a phase III randomized trial
    Michele Reni, Elisa Bonetto, Stefano Sergio Cordio et al. · 2006 · Pancreatology
  65. Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case–Control Consortium (PanC4)
    Cristina Bosetti, Ersilia Lucenteforte, Paige M. Bracci et al. · 2013 · Annals of Oncology
  66. A Quick Guide to Cancer Epidemiology
    Paolo Boffetta, Stefania Boccia, Carlo La Vecchia · 2014 · Springer eBooks
  67. Modified Appleby Procedure for Resection of Tumors of the Pancreatic Body and Tail with Celiac Axis Involvement
    Rory L. Smoot, John H. Donohue · 2012 · Journal of Gastrointestinal Surgery
  68. Molecular genetics and related developments in pancreatic cancer
    Ralph H. Hruban, Michael Goggins, Scott E. Kern · 1999 · Current Opinion in Gastroenterology
  69. Preoperative modified FOLFIRINOX (mFOLFIRINOX) followed by chemoradiation (CRT) for borderline resectable (BLR) pancreatic cancer (PDAC): Initial results from Alliance Trial A021101.
    Matthew H. G. Katz, Qian Shi, Syed Arif Ahmad et al. · 2015 · Journal of Clinical Oncology
  70. Stent treatment of malignant gastric outlet obstruction: the effect on rate of gastric emptying, symptoms, and survival
    Lene Larssen, Truls Hauge, Asle W. Medhus · 2012 · Surgical Endoscopy
  71. Anti-cancer effects of oncolytic viral therapy combined with photodynamic therapy in human pancreatic cancer cell lines
    Yazan S. Khaled, Kathleen E. Wright, Alan A. Melcher · 2015 · The Lancet
  72. Impact of Gemcitabine Chemotherapy and 3-Dimensional Conformal Radiation Therapy/5-Fluorouracil on Quality of Life of Patients Managed for Pancreatic Cancer
    Michala Short, David Goldstein, Georgia K. B. Halkett · 2012 · International Journal of Radiation Oncology*Biology*Physics
  73. FOLFIRINOX versus gemcitabine in patients with metastatic pancreatic cancer
    Thierry Conroy · 2011 · Cancéro digest
  74. The Role of End-of-Life Issues in the Design and Reporting of Cancer Clinical Trials: A Structured Literature Review
    Jan Gaertner, Vera Weingärtner, Stefan Lange, Elke Hausner, Ansgar Gerhardus, Steffen T. Simon, Raymond Voltz, Gerhild Becker, Norbert Schmacke · 2015 · PLoS ONE
  75. Gene signatures from pancreatic cancer tumor and stromal cells predict disease outcome
    Filippos Kottakis, Nabeel M. Bardeesy · 2015 · Nature Genetics